Effect of N(G)-nitro-L-arginine on age-related changes of glutamate receptor systems and immunophilin in rats

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 6, 1997, Pages 373-381

  Araki, Tsutomu ^c   Oshima, Yoshiteru ^a   Kato, Hiroyuki ^c   Shuto, Katsuro ^b   Itoyama, Yasuto ^c  

^a TOHOKU UNIVERSITY   (Japan)

^b Pharmacological Research Laboratory   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; Excitatory amino acid transport; FK 506; Glycine; Immunophilin; MK 801; Nitric oxide synthase inhibitor

Indexed keywords

DIZOCILPINE; GLUTAMATE RECEPTOR; IMMUNOPHILIN; N(G) NITROARGININE; TACROLIMUS; AMINO ACID RECEPTOR BLOCKING AGENT; CARRIER PROTEIN; DIZOCILPINE MALEATE; ENZYME INHIBITOR; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER;

AGING; AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBELLUM CORTEX; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; IMMUNOHISTOCHEMISTRY; LEARNING; MEMORY; NERVE CELL PLASTICITY; NERVE FUNCTION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; RAT; TISSUE INJURY; ANIMAL; AUTORADIOGRAPHY; BINDING SITE; BRAIN; COMPARATIVE STUDY; FISCHER 344 RAT; MALE; METABOLISM;

AGING; ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BRAIN; CARRIER PROTEINS; DIZOCILPINE MALEATE; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; MALE; NG-NITROARGININE METHYL ESTER; RATS; RATS, INBRED F344; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030612878     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Garthwaite, J. Glutamate, nitric oxide and cell-cell signalling in the central nervous system. Trend Neurosci 1991, 14: 60-7.
2. Bohme, G.A., Bon, C., Strutzmann, J.M., Doble, A., Blanchard, J.C., Possible involvement of nitric oxide in long term potentiation. Eur J Pharmacol 1991, 199: 379-81.
3. Dawson, V.L., Dawson, T.M., London, E.D., Bredt, D.S., Snyder, S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical culture. Proc Natl Acad Sci USA 1991, 88: 6368-71.
4. Daniel, H., Hermart, N., Jailard, D., Crepel, F. Long-term depression requires nitric oxide and guanosine 3':5'cyclic monophosphate production in rat cerebellum. Eur J Neurosci 1993, 5: 1079-82.
5. Bredt, D.S., Hwang, P.M., Snyder, S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990, 347: 768-70.
6. Nowicki, J.P., Duval, D., Poignet, H., Scatton, B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol 1991, 204: 339-40.
7. Buisson, A., Plotkine, M., Boulu, R.G. The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal ischemia. Br J Pharmacol 1992, 106: 766-7.
8. Yamamolo, S., Golanov, E.V., Berger, S.B., Reis, D.J. Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat. J Cereb Blood Flow Metab 1992, 12: 717-26.
9. Zhang, F., Iadecola, C. Nitroprusside improves blood flow and reduces brain damage after focal ischemia. NeuroReport 1993, 4: 559-62.
10. Iadecola, C., Pelligrino, D.A., Moskowitz, M.A., Lassen, N. A. State of the art review: Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 1994, 14: 175-92.
11. Rothman, S.M., Olney, J.W. Glutamate and the pathology of hypoxic/ischemic brain damage. Ann Neurol 1986, 19: 105-11.
12. Siesjö, B.K., Wieloch, T. Epileptic brain damage: Pathophysiology and neurochemical pathology. Adv Neurol 1986, 22: 813-47.
13. Wieloch, T. Endogenous excitotoxins as possible mediators of ischemic and hypoglycemic brain damage. Prog Brain Res 1986, 63: 69-85.
14. Thomas, R.J. Excitatory amino acids in health and disease. J Am Geriatr Soc 1995, 43: 1279-89.
15. Kollegger, H., McBean, G.J., Tipton, K.F. Reduction of striatal N-methyl-D-aspartate toxicity by inhibition of nitric oxide synthase. Biochem Pharmacol 1993, 45: 260-4.
16. Haberny, K.A., Pou, S., Eccles, C.U. Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis. Neurosci Lett 1992, 146: 187-90.
17. MacKenzie, G.M., Jenner, P., Marsden, C.D. The effect of nitric oxide synthase inhibition on quinolinic acid toxicity in the rat striatum. Neuroscience 1995, 67: 357-71.
18. Haley, J.E., Wilcox, G.L., Chapman, P.F. The role of nitric oxide in hippocampal long-term potentiation. Neuron 1992, 8: 211-6.
19. 2+-independent synaptic vesicle release. Neuron 1994, 12: 1235-44.
20. Shibuki, K., Okada, D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 1991, 349: 326-8.
21. Boulton, C.L., Irving, A.J., Southam, E., Potier, B., Garthwaite, J., Collingridgc, G.L. The nitric oxide-cyclic GMP pathway and synaptic depression in rat hippocampal slices. Eur J Neurosci 1994, 6: 1528-35.
22. Sun, P., Kanthasamy, A., Yim, G.K., Isom, G.E. Inhibition of potassium-stimulated dopamine release by the nitric oxide generator isosorbide dinitrate. Neuropharmacology 1995, 34: 205-10.
23. 3H]MK-801 binding sites in mammalian brain. Br J Pharmacol 1988, 93: 944-54.
24. Araki, T., Kato, H., Kogure, K., Kanal, Y. Long-term changes in gerbil brain neurotransmitter system receptors following transient cerebral ischaemia. Br J Pharmacol 1992, 107: 437-42.
25. Miyoshi, R., Kito, S., Doudou, N., Nomoto, N. Age-related changes of strychnine-insensitive glycine receptors in rat brain an studied by in vitro autoradiography. Synapse 1990, 6: 338-43.
26. 3H]-glycine binding in the gerbil brain after cerebral ischemia. Eur J Pharmacol 1995, 278: 91-6.
27. Anderson, K.J., Monaghan, D.T., Bridges, R.J., Tavoularis, A.L., Cotman, C.W. Autoradiographic characterization of putative excitatory acid transport sites. Neuroscience 1990, 38: 311-22.
28. Anderson, K.J., Bridges, R.J., Cotman, C.W. Increased density of excitatory amino acid transport sites in the hippocampal formation following an entorhinal lesion. Brain Res 1991, 562: 285-90.
29. Steiner, J.P., Dawson, T.M., Fotuchi, M. et al. High brain densities of immunophilin FKBP colocalized with calcineurin. Nature 1992, 358: 584-7.
30. Moncada, S., Palmer, R.M., Higgs, E.A. Nitric oxide: Physiology, pathology and pharmacology. Pharmacol Rev 1991, 43: 109-42.
31. Dawson, T.M., Snyder, S.H. Gases as biological messengers: Nitric oxide and carbon monoxide in the brain. J Neurosci 1994, 14: 5147-59.
32. Marletta, M.A. Nitric oxide synthase structure and mechanism. J Biol Chem 1993, 268: 12231-4.
33. Marletta, M.A. Nitric oxide synthase: Aspects concerning structure and catalysis. Cell 1994, 78: 927-30.
34. Knowles, R.G., Palacios, M., Palmer, R.M.J., Moncada, S. Formation of nitric oxide in the central nervous system: A transduction mechanism for stimulation of the soluble guanyl cyclase. Proc Natl Acad Sci USA 1989, 86: 5159-62.
35. Hope, B.T., Michael, G.J., Knigge, K.M., Vincent, S.R. Neuronal NADPH diaphorase is a nitric oxide synthetase. Proc Natl Acad Sci USA 1991, 88: 2811-4.
36. G-nitro-arginine binding in rat brain. Neuropharmacology 1995, 34: 63-73.
37. Prast, H., Philippu, A. Nitric oxide releases acetylcholine in the basal forebrain. Eur J Pharmacol 1992, 216: 139-40.
38. Lonart, G., Wang, J., Johanson, K.M. Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharmacol 1992, 220: 271-2.
39. Zhu, X.-Z., Luo, L.-G. Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J Neurochem 1992, 59: 932-5.
40. 3H]dopamine and pH]glutamate by striatal synaptosomes. J Neurochem 1994, 63: 2108-17.
41. 3H]strychnine binding sites in rat brain. Eur J Pharmacol 1986, 126: 303-7.
42. 3H]glycine binding sites in rat brain by quantitative receptor autoradiography. Neuroscience 1990, 35: 653-68.
43. Johnson, J.W., Ascher, P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987, 325: 529-31.
44. 3H]glutamate binding sites in rat brain. J Neurosci 1985, 5: 2909-19.
45. Fonnum, F. Glutamate: A neurotransmitter in mammalian brain. J Neurochem 1984, 41: 1-11.
46. Liu, J., Farmer, J.D., Jr., Lane, W.S., Friedman, J., Weissman, I., Schreiber, S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK-506 complexes. Cell 1991, 66: 807-15.
47. Dawson, T.M., Steiner, J.P., Dawson, V.L., Dinerman, J.L., Uhl, G.R., Snyder, S.H. Immunosuppressant FK-506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA 1993, 90: 9808-12.
48. Araki, T., Kato, H., Shuto, K., Fujiwara, T., Itoyama Y. Effect of nitric oxide synthase inhibitor on age-related changes in second messenger systems and calcium channels in rats. Metabolic Brain Dis 1997, 12: 83-92.